These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 33382017)

  • 21. Inhibitor binding studies of
    Mallavarapu BD; Abdullah M; Saxena S; Guruprasad L
    J Biomol Struct Dyn; 2019 Sep; 37(14):3751-3763. PubMed ID: 30239262
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-tubercular activity evaluation of natural compounds by targeting Mycobacterium tuberculosis resuscitation promoting factor B inhibition: An in silico study.
    Rabaan AA; Garout M; Aljeldah M; Al Shammari BR; Alawfi A; Alshengeti A; Najim MA; Alrouji M; Almuhanna Y; Alissa M; Mashraqi MM; Alwashmi ASS; Alhajri M; Alateah SM; Farahat RA; Mohapatra RK
    Mol Divers; 2024 Jun; 28(3):1057-1072. PubMed ID: 36964456
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparative modeling and molecular docking study on Mycobacterium tuberculosis targets involved in peptidoglycan biosynthesis.
    Fakhar Z; Naiker S; Alves CN; Govender T; Maguire GE; Lameira J; Lamichhane G; Kruger HG; Honarparvar B
    J Biomol Struct Dyn; 2016 Nov; 34(11):2399-417. PubMed ID: 26612108
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of new benzamide inhibitor against α-subunit of tryptophan synthase from Mycobacterium tuberculosis through structure-based virtual screening, anti-tuberculosis activity and molecular dynamics simulations.
    Naz S; Farooq U; Ali S; Sarwar R; Khan S; Abagyan R
    J Biomol Struct Dyn; 2019 Mar; 37(4):1043-1053. PubMed ID: 29502488
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of potent L,D-transpeptidase 5 inhibitors for Mycobacterium tuberculosis as potential anti-TB leads: virtual screening and molecular dynamics simulations.
    Sabe VT; Tolufashe GF; Ibeji CU; Maseko SB; Govender T; Maguire GEM; Lamichhane G; Honarparvar B; Kruger HG
    J Mol Model; 2019 Oct; 25(11):328. PubMed ID: 31656981
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Virtual screening for the identification of novel inhibitors of Mycobacterium tuberculosis cell wall synthesis: inhibitors targeting RmlB and RmlC.
    Ren JX; Qian HL; Huang YX; Zhu NY; Si SY; Xie Y
    Comput Biol Med; 2015 Mar; 58():110-7. PubMed ID: 25637777
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of the Seaweed Metabolites as Potential Anti-tubercular Agents Against Human Pantothenate synthetase: An In Silico Approach.
    Arokia Rajan MS; Thirunavukkarasu R; Joseph J; Palliyath GK; Somarathinam K; Kothandan G; Subaramaniyan K; Ullah R; Rajesh RP
    Curr Microbiol; 2023 Aug; 80(10):318. PubMed ID: 37578562
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exploring the interaction mechanism between potential inhibitor and multi-target Mur enzymes of mycobacterium tuberculosis using molecular docking, molecular dynamics simulation, principal component analysis, free energy landscape, dynamic cross-correlation matrices, vector movements, and binding free energy calculation.
    Kumari M; Singh R; Subbarao N
    J Biomol Struct Dyn; 2022; 40(24):13497-13526. PubMed ID: 34662260
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Discovery of Mycobacterium tuberculosis α-1,4-glucan branching enzyme (GlgB) inhibitors by structure- and ligand-based virtual screening.
    Dkhar HK; Gopalsamy A; Loharch S; Kaur A; Bhutani I; Saminathan K; Bhagyaraj E; Chandra V; Swaminathan K; Agrawal P; Parkesh R; Gupta P
    J Biol Chem; 2015 Jan; 290(1):76-89. PubMed ID: 25384979
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identifying the analogues of berberine as promising antitubercular drugs targeting Mtb-FtsZ polymerisation through ligand-based virtual screening and molecular dynamics simulations.
    Akinpelu OI; Kumalo HM; Mhlongo SI; Mhlongo NN
    J Mol Recognit; 2022 Feb; 35(2):e2940. PubMed ID: 34910337
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of potential inhibitors of
    Kamera S; Sharma VK; Prasad V B; Garlapati A
    J Biomol Struct Dyn; 2023 Aug; ():1-15. PubMed ID: 37526169
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Refined homology model of cytochrome bcc complex B subunit for virtual screening of potential anti-tuberculosis agents.
    Pan Z; Wang Y; Gu X; Wang J; Cheng M
    J Biomol Struct Dyn; 2020 Oct; 38(16):4733-4745. PubMed ID: 31674290
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discovery of new inhibitors of Mycobacterium tuberculosis EPSP synthase - A computational study.
    Dahmer BR; Ethur EM; Timmers LFSM
    J Mol Graph Model; 2023 Jun; 121():108404. PubMed ID: 36907015
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Computational discovery of potent drugs to improve the treatment of pyrazinamide resistant Mycobacterium tuberculosis mutants.
    Jagadeb M; Rath SN; Sonawane A
    J Cell Biochem; 2018 Sep; 119(9):7328-7338. PubMed ID: 29761826
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structure-based drug design, synthesis and screening of MmaA1 inhibitors as novel anti-TB agents.
    Veeravarapu H; Malkhed V; Mustyala KK; Vadija R; Malikanti R; Vuruputuri U; Muthyala MKK
    Mol Divers; 2021 Feb; 25(1):351-366. PubMed ID: 32533514
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In Silico Identification of Possible Inhibitors for Protein Kinase B (PknB) of
    Vieira TF; Martins FG; Moreira JP; Barbosa T; Sousa SF
    Molecules; 2021 Oct; 26(20):. PubMed ID: 34684743
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
    Tomioka H
    Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structure-based identification of natural compound inhibitor against
    Lata S; Akif M
    J Biomol Struct Dyn; 2021 Aug; 39(12):4480-4489. PubMed ID: 32567497
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacophore model-based virtual screening, docking, biological evaluation and molecular dynamics simulations for inhibitors discovery against
    Naz S; Farooq U; Khan S; Sarwar R; Mabkhot YN; Saeed M; Alsayari A; Muhsinah AB; Ul-Haq Z
    J Biomol Struct Dyn; 2021 Feb; 39(2):610-620. PubMed ID: 31937192
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An integrated computational approach of molecular dynamics simulations, receptor binding studies and pharmacophore mapping analysis in search of potent inhibitors against tuberculosis.
    Agarwal S; Verma E; Kumar V; Lall N; Sau S; Iyer AK; Kashaw SK
    J Mol Graph Model; 2018 Aug; 83():17-32. PubMed ID: 29753941
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.